Transaction #1690 · Form 4 · 0001617541-25-000005
Prelude Therapeutics Inc · Stock award · Director Stock Option (Right to Buy)
Prelude Therapeutics Inc · Transacted October 17, 2025 · Filed October 20, 2025
What does this filing report?
An SEC Form 4 filing for Prelude Therapeutics Inc records a stock award involving Director Stock Option (Right to Buy) on October 17, 2025. The reported quantity was 76,000. The filing date is October 20, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Prelude Therapeutics Inc
- Company CIK
- 0001678660
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 76,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 76,000
- Ownership description
- Not reported
- SEC acceptance time
- Oct 20, 2025, 4:16 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Dorton Katina ↗
Director
CIK 0001617541
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 76,000
- Conversion / exercise price
- 1.19
- Exercise date
- Not reported
- Expiration date
- October 16, 2035
Filing footnotes & remarks
- F1
- The option award vests over a three year period equally one-thirty-sixth per month, subject to Reporting Person's continued service to the Company on each vesting date.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.